Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial

Published:2018-11 Issue:11 Volume:19 Page:1437-1448
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Shitara Kohei,Doi Toshihiko,Dvorkin Mikhail,Mansoor Wasat,Arkenau Hendrik-Tobias,Prokharau Aliaksandr,Alsina Maria,Ghidini Michele,Faustino Catia,Gorbunova Vera,Zhavrid Edvard,Nishikawa Kazuhiro,Hosokawa Ayumu,Yalçın Şuayib,Fujitani Kazumasa,Beretta Giordano D,Cutsem Eric Van,Winkler Robert E,Makris Lukas,Ilson David H,Tabernero Josep

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Second-line treatments: moving towards an opportunity to improve survival in advanced gastric cancer?;Salati;ESMO Open,2017

2. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Smyth;Ann Oncol,2016

3. Japanese gastric cancer treatment guidelines 2014 (version 4);Gastric Cancer,2017

4. Gastric cancer;Van Cutsem;Lancet,2016

Cited by 383 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measurement of changes in serum-based inflammatory indicators to monitor response to nivolumab monotherapy in advanced gastric cancer: a multicenter retrospective study;BMC Cancer;2024-09-09

2. Safety and efficacy of first-line nivolumab plus chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: real-world data analysis;ESMO Gastrointestinal Oncology;2024-09

3. Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trial;Digestive and Liver Disease;2024-08

4. The safety and efficacy outcomes of Minnelide given alone or in combination with paclitaxel in advanced gastric cancer: A phase I trial;Cancer Letters;2024-08

5. Emerging Therapeutic Targets and Future Directions in Advanced Gastric Cancer: A Comprehensive Review;Cancers;2024-07-29